LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:LegoChem Biosciences Inc (141080) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8101
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antibiotics, anticoagulants, anticancer and anti-inflammation. LCB’s services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services comprise metabolic stability, plasma stability, protein binding, and cell toxicity. LCB also offers compound synthesis and process development services. It conducts research programs through co-developments, joint researches, and global pharmaceutical companies. The company has operations in Seoul and Anseong, South Korea.LCB is headquartered in Daejeon, South Korea.

LegoChem Biosciences Inc (141080) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novimmune and LegoChem Biosciences Enter into Research Agreement 11
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 12
LegoChem Biosciences Enters into Joint Venture Agreement with Geom Therapeutics 13
Y-Biologics Enters into Agreement with LegoChem Biosciences 14
LegoChem Biosciences Enters into Agreement with Theranyx 15
Seasun Biomaterials Enters into Agreement with LegoChem Biosciences 16
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 17
AstraZeneca Enters into Agreement with LegoChem for Antibiotic-Resistant Bacterial Infections 18
LegoChem Biosciences Enters into Research Agreement with Sanofi 19
Licensing Agreements 20
Geom Therapeutics Enters into Licensing Agreement with LegoChem Biosciences 20
Bridge Biotherapeutics Enters into Licensing Agreement with LegoChem Biosciences 21
Millennium Pharma Enters into Licensing Agreement with LegoChem Biosciences 22
LegoChem Biosciences Enters Licensing Agreement with RMX Biopharma 23
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 24
Equity Offering 25
LegoChem Biosciences Raises USD4.2 Million in Rights Offering 25
LegoChem Biosciences Raises USD21.8 Million in Private Placement of Shares 26
Debt Offering 27
LegoChem Biosciences Raises USD9.3 Million in Private Placement of Bonds 27
LegoChem Biosciences Inc – Key Competitors 28
LegoChem Biosciences Inc – Key Employees 29
LegoChem Biosciences Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LegoChem Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Novimmune and LegoChem Biosciences Enter into Research Agreement 11
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 12
LegoChem Biosciences Enters into Joint Venture Agreement with Geom Therapeutics 13
Y-Biologics Enters into Agreement with LegoChem Biosciences 14
LegoChem Biosciences Enters into Agreement with Theranyx 15
Seasun Biomaterials Enters into Agreement with LegoChem Biosciences 16
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 17
AstraZeneca Enters into Agreement with LegoChem for Antibiotic-Resistant Bacterial Infections 18
LegoChem Biosciences Enters into Research Agreement with Sanofi 19
Geom Therapeutics Enters into Licensing Agreement with LegoChem Biosciences 20
Bridge Biotherapeutics Enters into Licensing Agreement with LegoChem Biosciences 21
Millennium Pharma Enters into Licensing Agreement with LegoChem Biosciences 22
LegoChem Biosciences Enters Licensing Agreement with RMX Biopharma 23
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 24
LegoChem Biosciences Raises USD4.2 Million in Rights Offering 25
LegoChem Biosciences Raises USD21.8 Million in Private Placement of Shares 26
LegoChem Biosciences Raises USD9.3 Million in Private Placement of Bonds 27
LegoChem Biosciences Inc, Key Competitors 28
LegoChem Biosciences Inc, Key Employees 29
LegoChem Biosciences Inc, Other Locations 30

List of Figures
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SMS Pharmaceuticals Ltd (SMSPHARMA):企業の財務・戦略的SWOT分析
    SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析
    Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Warehouse Group Ltd (WHS):企業の財務・戦略的SWOT分析
    The Warehouse Group Ltd (WHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hydrogenics Corporation (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corporation (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • OncoMed Pharmaceuticals Inc (OMED):企業の財務・戦略的SWOT分析
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • Briscoe Group Ltd (BGP):企業の財務・戦略的SWOT分析
    Briscoe Group Ltd (BGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Anglo American Plc:企業のM&A・事業提携・投資動向
    Anglo American Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo American Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Abu Dhabi National Energy Co (TAQA):電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi National Energy Company (TAQA), a subsidiary of government-owned Abu Dhabi Water and Electricity Authority, is an energy and water company. It undertakes power generation; exploration, development, production and storage of oil and gas; pipelines and gas storage; and water desalina …
  • Michelin SCA (ML):企業の財務・戦略的SWOT分析
    Michelin SCA (ML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Laboratorios Liomont SA de CV-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorios Liomont SA de CV (Liomont) is a healthcare products provider that offers research and develops medicines for medication, prescription and OTC markets. The company offers prescription medication products and over the counter products. It offers drugs in serves various therapeutic …
  • ING Bank NV:企業のM&A・事業提携・投資動向
    ING Bank NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ING Bank NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • BASF India Ltd (BASF):企業の財務・戦略的SWOT分析
    Summary BASF India Ltd (BASF) a subsidiary of BASF SE is a chemical company that manufactures and distributes specialty chemicals, performance products, plastics and crop protection products. The company offers chemical products such as intermediates, monomers and petrochemicals. Its performance pro …
  • Arab National Bank:企業の戦略・SWOT・財務情報
    Arab National Bank - Strategy, SWOT and Corporate Finance Report Summary Arab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pentair plc:企業の戦略・SWOT・財務情報
    Pentair plc - Strategy, SWOT and Corporate Finance Report Summary Pentair plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • Banco del Pichincha CA:企業の戦略・SWOT・財務分析
    Banco del Pichincha CA - Strategy, SWOT and Corporate Finance Report Summary Banco del Pichincha CA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Louis Dreyfus Company B.V.:企業の戦略的SWOT分析
    Louis Dreyfus Company B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hitachi Metals, Ltd.:企業の戦略・SWOT・財務分析
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • La Plata Electric Association, Inc.:発電所・企業SWOT分析
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆